• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

State Farm Ventures: Investment Portfolio & Startup News

State Farm Ventures

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Lumai raises £8m Series A led by Constructor Capital to reduce AI data centre costs and energy useLumai raises £8m Series A led by Constructor Capital to reduce AI data centre costs and energy use
    Lumai
    2 Apr 2025

    Lumai raises £8m Series A led by Constructor Capital to reduce AI data centre costs and energy use

    Lumai develops optical computing hardware that accelerates AI inference while significantly reducing power consumption and costs in data centres.

    InsureVision lands £2m seed led by Rethink Ventures, Twin Path Ventures and State Farm Ventures to advance AI vehicle risk assessmentInsureVision lands £2m seed led by Rethink Ventures, Twin Path Ventures and State Farm Ventures to advance AI vehicle risk assessment
    InsureVision
    7 Mar 2025

    InsureVision lands £2m seed led by Rethink Ventures, Twin Path Ventures and State Farm Ventures to advance AI vehicle risk assessment

    InsureVision develops AI-powered contextual driving risk assessment software that analyses video footage to improve insurance underwriting, fleet safety and advanced driver assistance systems.

State Farm Ventures
    • Deep Tech
    • Fintech
  • ventures.statefarm.com

More venture news

  • Boltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design
    Boltz
    18 Nov 2026

    Boltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design

    Series ALife Sciences
  • Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre
    Zya
    16 Nov 2026

    Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre

    Series AHealth
  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn